| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |